News

Dr. Asim Mohammad Shahid discusses seizures and epilepsy that can impact children. He goes over febrile seizures, their causes, and addresses the misconceptions surrounding its occurrence related to vaccinations. He provides an overview of the common types of seizures that parents may see their child experience and how to best manage the frightening experience. He also emphasizes the importance of timely medical intervention when epilepsy occurs.

Listen here: https://weillcornell.org/patient-education/podcasts/kids-health-cast

A Weill Cornell Medicine investigator and other members of a technical advisory group to the World Health Organization and United Nations Children’s Fund have outlined measures that nations can take to ensure that children’s health is accounted for within climate change goals. The authors discuss concrete and achievable indicators in a commentary published Oct. 1 in The Lancet Planetary Health.

“Children have specific needs that often get overlooked,” said lead author Dr. Ilan Cerna-Turoff, an assistant professor of epidemiology in emergency medicine at Weill Cornell Medicine. “We’re making sure that doesn’t happen.”

headshot of a man

Dr. Ilan Cerna-Turoff. Credit: Travis Curry

Dr. Sallie Permar discusses how vaccines have changed pediatrics for the better, despite the field being at a financial disadvantage on Bloomberg News. Read more here!

Prior exposure to coronaviruses that cause ordinary colds can boost the immune system’s ability to attack a vulnerable site on the COVID-19-causing coronavirus SARS-CoV-2, according to a study led by investigators at Weill Cornell Medicine. The finding suggests a new vaccination strategy that might provide broader and more durable protection against SARS-CoV-2 strains compared with existing vaccines—and might also protect against other emergent coronaviral threats.

In the study, published Oct. 9 in the Journal of Experimental Medicine, the researchers analyzed human antibody responses to the base of SARS-CoV-2’s outer spike protein. This segment, known as the S2 subunit, mediates the coronavirus’s entry into a host cell, and because of this critical function does not vary much between different coronavirus subfamilies. Thus, targeting it successfully could help provide broad protection against existing and future coronavirus threats. Although exposure to SARS-CoV-2 alone elicits a weak antibody response against S2, the researchers found evidence that prior exposure to common cold coronaviruses, especially one called OC43, can prime the immune system for a much more effective anti-S2 response—one that may be able to neutralize a wide range of coronaviruses.

Dr. Sallie R. Permar, MD, PhD delivered the prestigious Stanley A. Plotkin Lecture in Vaccinology Oct. 21 at the annual meeting of the Pediatric Infectious Diseases Society (PIDS), held in Atlanta, Ga. Dr. Plotkin is a vaccine hero who developed the rubella vaccine, among others. At a time when science and vaccine science are under attack, it was an energizing meeting of minds to come together as researchers, physicians and advocates to stand up for and celebrate public health.

The Stanley A. Plotkin Lecture in Vaccinology is an honor bestowed by PIDS to a distinguished scientist whose work has significantly impacted pediatric vaccinology and infectious diseases. Dr. Plotkin, founder of PIDS, has served as a mentor to Dr. Permar and both nominated and poignantly introduced her for his namesake lecture. 

Dr. Sallie Permar, top pediatrician and a parent, shares why she vaccinated her children and reminds parents to keep their kids protected - especially since COVID-19 is already circulating around.

Pediatricians highly recommended vaccination for children from 6 months to 18 years old.

Here's What We Know: Parents want to keep their kids healthy and missing school is hard on the entire family. Vaccination helps prevent or lessen symptoms and reduces the risk of passing it on to others.

If your child isn't feeling well or you're unsure about what to do, talk to your pediatrician for more guidance.

Watch Dr. Permar's video to learn more.

Remember the novel coronavirus? A virus never before seen in humans? Remember the lockdowns, social distancing and masks that were our only means of protecting ourselves from that deadly new virus?  

In the midst of  the greatest public health emergency since the flu pandemic of 1918, scientists took a new  vaccine  technology, based on mRNA, and ran with it.  

Among preterm newborns, greater exposure to the mother’s voice after birth appeared to speed up the maturation of a key language-related brain circuit, in a small clinical trial conducted by investigators at Weill Cornell Medicine, Burke Neurological Institute and Stanford Medicine. The finding provides direct experimental support for the idea that a mother’s voice promotes her child’s early language-related brain development. It also hints that boosting exposure to maternal speech might ameliorate the language development delays often seen among children born prematurely.

The study, published Oct. 14 in Frontiers in Human Neuroscience, included 46 preterm infants who were born at just 24 to 31 weeks gestational age. Half received routine exposure to the mother’s voice, while the other half had routine exposure augmented with multiple daily audio recordings of the mother’s voice. Later MRI scans of the infants’ brains suggested significantly greater maturation in the left arcuate fasciculus, a brain circuit known to be involved in speech and language processing.

“Kangaroo care,” or skin-to-skin contact, may be neuroprotective and is associated with neonatal development in areas of the brain involved in emotional regulation in preterm infants, according to a new preliminary study from Weill Cornell Medicine, Burke Neurological Institute and Stanford Medicine investigators. Even short sessions correlated with noticeable effects on brain imaging scans, which is important because more than half of preterm infants have risk for neurodevelopmental impairment.  

The findings of the retrospective study, published Sept. 24 in Neurology, the medical journal of the American Academy of Neurology, could ultimately lead to better neurological outcomes for preterm infants and a wider adoption of kangaroo care in neonatal intensive care units (NICUs).

A multi-institutional team led by Weill Cornell Medicine investigators has been awarded a five-year, $20.8 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, for advanced preclinical development of a promising experimental HIV vaccine.

A successful vaccine to prevent new HIV infections would be a major public health breakthrough. About 1.3 million people acquired HIV in 2024, according to the World Health Organization, and at the end of that year an estimated 41 million people were living with the virus. Medication can keep individuals healthy but must be taken for a lifetime.

woman in a white coat

Dr. Sallie Permar. Credit: Brad Trent

Pediatrics Weill Cornell Medicine Appointments & Referrals: (646) 962-KIDS (646) 962-5437 Chair's Office: Weill Cornell Medicine 525 E 68th St.
Box 225
New York, NY 10065 (646) 962-5437